Wei Yang

This inventor holds 32 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Peptide Therapeutics. Top assignee: Palatin Technologies Incorporated. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Yang. Retrieved from https://idiyas.com/inventor/wei-yang-q0ta6yz9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 2)

% Patents Active = 81.3

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 169(Granted Patents)

Company Filing History:

32 out of 68

Palatin Technologies Incorporated

patents

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Melanocortin Receptor

Cyclic Peptides

Peptide Therapeutics

Inflammation Therapy

Cytokine Storm

Sexual Dysfunction

Peptidomimetics

Natriuretic Peptides

Metallopeptides

Amino Acid Surrogates

Peptide Compositions

Cyclic Hexapeptides

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692291 - Diamine-Linked Melanocortin Receptor-Specific Cyclic Peptides for Ocular Indications (2026-07-28),

2. 11286280 - Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation therapy (2022-03-29),

3. 10711039 - Melanocortin receptor-specific peptide with C-terminal naphthylalanine (2020-07-14),

4. 10632171 - Melanocortin receptor-specific peptides (2020-04-28),

5. 10179804 - Melanocortin receptor-specific peptides (2019-01-15),

6. 10106578 - Melanocortin-1 receptor-specific linear peptides (2018-10-23),

7. 10017539 - Melanocortin-1 receptor-specific cyclic hexapeptides (2018-07-10),

8. 9580466 - Melanocortin-1 receptor-specific linear peptides (2017-02-28),

9. 9458201 - Melanocortin receptor-specific heptapeptides (2016-10-04),

10. 9447148 - Melanocortin-1 receptor-specific cyclic peptides (2016-09-20),

11. 9273098 - Lactam-bridged melanocortin receptor-specific peptides (2016-03-01),

12. 8933194 - Melanocortin-1 receptor-specific linear peptides (2015-01-13),

13. 8877890 - Melanocortin-1 receptor-specific cyclic peptides (2014-11-04),

14. 8846601 - Melanocortin receptor-specific peptides (2014-09-30),

15. 8729224 - Melanocortin receptor-specific peptides for treatment of female sexual dysfunction (2014-05-20),

Title: The Innovative Journey of Wei Yang

Introduction: Wei Yang, a visionary inventor based in Edison, NJ, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: Wei Yang's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics in healthcare, a revolutionary renewable energy storage system, and a state-of-the-art cybersecurity software for safeguarding sensitive data.

Career Highlights: With a career spanning over two decades, Wei Yang has established himself as a leading figure in the tech industry. His notable achievements include being recognized as the Inventor of the Year by the United States Patent and Trademark Office and receiving multiple awards for his innovative solutions.

Collaborations: Wei Yang has collaborated with top research institutions, leading tech companies, and renowned universities to further advance his inventions. His partnerships have led to the development of groundbreaking technologies that have reshaped various sectors.

Conclusion: Wei Yang's relentless pursuit of innovation and his passion for creating solutions that address real-world challenges have solidified his reputation as a trailblazing inventor. His contributions continue to inspire the next generation of innovators to push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.